Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment

Identifieur interne : 000E98 ( PascalFrancis/Corpus ); précédent : 000E97; suivant : 000E99

Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment

Auteurs : Yoshiyuki Hosokai ; Yoshiyuki Nishio ; Kazumi Hirayama ; Atsushi Takeda ; Toshiyuki Ishioka ; Yoichi Sawada ; Kyoko Suzuki ; Yasuto Itoyama ; Shoki Takahashi ; Hiroshi Fukuda ; Etsuro Mori

Source :

RBID : Pascal:09-0223194

Descripteurs français

English descriptors

Abstract

There is no consensus with regard to the clinical and neuroimaging characteristics of prodromal dementia in Parkinson's disease (PD). To delineate functional neuroimaging features of PD with mild cognitive impairment (PDMCI) and with no cognitive impairment (PDNC), we compared regional cerebral glucose metabolism (CMRglc) amongst 13 patients with PDMCI, 27 with PDNC, and 13 healthy controls. The PDNC patients had limited areas of hypometabolism in the frontal and occipital cortices. In the PDMCI patients, there were extensive areas of hypometabolism in the posterior cortical regions, including the temporo-parieto-occipital junction, medial parietal, and inferior temporal cortices. The present results suggest that posterior cortical dysfunction is the primary neuroimaging feature of PD patients at risk for dementia.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 24
A06       @2 6
A08 01  1  ENG  @1 Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment
A11 01  1    @1 HOSOKAI (Yoshiyuki)
A11 02  1    @1 NISHIO (Yoshiyuki)
A11 03  1    @1 HIRAYAMA (Kazumi)
A11 04  1    @1 TAKEDA (Atsushi)
A11 05  1    @1 ISHIOKA (Toshiyuki)
A11 06  1    @1 SAWADA (Yoichi)
A11 07  1    @1 SUZUKI (Kyoko)
A11 08  1    @1 ITOYAMA (Yasuto)
A11 09  1    @1 TAKAHASHI (Shoki)
A11 10  1    @1 FUKUDA (Hiroshi)
A11 11  1    @1 MORI (Etsuro)
A14 01      @1 Department of Radiological Technology and Science, School of Health Science, Tohoku University @2 Sendai @3 JPN @Z 1 aut.
A14 02      @1 Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University @2 Sendai @3 JPN @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut. @Z 11 aut.
A14 03      @1 Department of Neurology, Graduate School of Medicine, Tohoku University @2 Sendai @3 JPN @Z 4 aut. @Z 8 aut.
A14 04      @1 Department of Clinical Neuroscience, Graduate School of Medicine, Yamagata University @2 Yamagata @3 JPN @Z 7 aut.
A14 05      @1 Department of Diagnostic Radiology, Graduate School of Medicine, Tohoku University @2 Sendai @3 JPN @Z 9 aut.
A14 06      @1 Department of Radiology and Nuclear Medicine, Institute of Development, Aging, and Cancer, Tohoku University @2 Sendai @3 JPN @Z 10 aut.
A20       @1 854-862
A21       @1 2009
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000186181820090
A44       @0 0000 @1 © 2009 INIST-CNRS. All rights reserved.
A45       @0 32 ref.
A47 01  1    @0 09-0223194
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 There is no consensus with regard to the clinical and neuroimaging characteristics of prodromal dementia in Parkinson's disease (PD). To delineate functional neuroimaging features of PD with mild cognitive impairment (PDMCI) and with no cognitive impairment (PDNC), we compared regional cerebral glucose metabolism (CMRglc) amongst 13 patients with PDMCI, 27 with PDNC, and 13 healthy controls. The PDNC patients had limited areas of hypometabolism in the frontal and occipital cortices. In the PDMCI patients, there were extensive areas of hypometabolism in the posterior cortical regions, including the temporo-parieto-occipital junction, medial parietal, and inferior temporal cortices. The present results suggest that posterior cortical dysfunction is the primary neuroimaging feature of PD patients at risk for dementia.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C03 01  X  FRE  @0 Maladie de Parkinson @2 NM @5 01
C03 01  X  ENG  @0 Parkinson disease @2 NM @5 01
C03 01  X  SPA  @0 Parkinson enfermedad @2 NM @5 01
C03 02  X  FRE  @0 Déficit cognitif léger @2 NM @5 02
C03 02  X  ENG  @0 mild cognitive impairment @2 NM @5 02
C03 02  X  SPA  @0 Disturbio cognitivo ligero @2 NM @5 02
C03 03  X  FRE  @0 Trouble cognitif @5 03
C03 03  X  ENG  @0 Cognitive disorder @5 03
C03 03  X  SPA  @0 Trastorno cognitivo @5 03
C03 04  X  FRE  @0 Pathologie du système nerveux @5 04
C03 04  X  ENG  @0 Nervous system diseases @5 04
C03 04  X  SPA  @0 Sistema nervioso patología @5 04
C03 05  X  FRE  @0 Encéphale @5 09
C03 05  X  ENG  @0 Encephalon @5 09
C03 05  X  SPA  @0 Encéfalo @5 09
C03 06  X  FRE  @0 Glucose @2 NK @5 10
C03 06  X  ENG  @0 Glucose @2 NK @5 10
C03 06  X  SPA  @0 Glucosa @2 NK @5 10
C03 07  X  FRE  @0 Métabolisme @5 11
C03 07  X  ENG  @0 Metabolism @5 11
C03 07  X  SPA  @0 Metabolismo @5 11
C03 08  X  FRE  @0 Tomoscintigraphie @5 12
C03 08  X  ENG  @0 Emission tomography @5 12
C03 08  X  SPA  @0 Tomocentelleografía @5 12
C03 09  X  FRE  @0 Tomographie par émission de positons @5 13
C03 09  X  ENG  @0 Positron emission tomography @5 13
C03 09  X  SPA  @0 Tomografía emisión positrones @5 13
C07 01  X  FRE  @0 Système nerveux central @5 37
C07 01  X  ENG  @0 Central nervous system @5 37
C07 01  X  SPA  @0 Sistema nervioso central @5 37
C07 02  X  FRE  @0 Pathologie de l'encéphale @5 38
C07 02  X  ENG  @0 Cerebral disorder @5 38
C07 02  X  SPA  @0 Encéfalo patología @5 38
C07 03  X  FRE  @0 Syndrome extrapyramidal @5 39
C07 03  X  ENG  @0 Extrapyramidal syndrome @5 39
C07 03  X  SPA  @0 Extrapiramidal síndrome @5 39
C07 04  X  FRE  @0 Maladie dégénérative @5 40
C07 04  X  ENG  @0 Degenerative disease @5 40
C07 04  X  SPA  @0 Enfermedad degenerativa @5 40
C07 05  X  FRE  @0 Pathologie du système nerveux central @5 41
C07 05  X  ENG  @0 Central nervous system disease @5 41
C07 05  X  SPA  @0 Sistema nervosio central patología @5 41
N21       @1 166
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 09-0223194 INIST
ET : Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment
AU : HOSOKAI (Yoshiyuki); NISHIO (Yoshiyuki); HIRAYAMA (Kazumi); TAKEDA (Atsushi); ISHIOKA (Toshiyuki); SAWADA (Yoichi); SUZUKI (Kyoko); ITOYAMA (Yasuto); TAKAHASHI (Shoki); FUKUDA (Hiroshi); MORI (Etsuro)
AF : Department of Radiological Technology and Science, School of Health Science, Tohoku University/Sendai/Japon (1 aut.); Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University/Sendai/Japon (1 aut., 2 aut., 3 aut., 5 aut., 6 aut., 7 aut., 11 aut.); Department of Neurology, Graduate School of Medicine, Tohoku University/Sendai/Japon (4 aut., 8 aut.); Department of Clinical Neuroscience, Graduate School of Medicine, Yamagata University/Yamagata/Japon (7 aut.); Department of Diagnostic Radiology, Graduate School of Medicine, Tohoku University/Sendai/Japon (9 aut.); Department of Radiology and Nuclear Medicine, Institute of Development, Aging, and Cancer, Tohoku University/Sendai/Japon (10 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 6; Pp. 854-862; Bibl. 32 ref.
LA : Anglais
EA : There is no consensus with regard to the clinical and neuroimaging characteristics of prodromal dementia in Parkinson's disease (PD). To delineate functional neuroimaging features of PD with mild cognitive impairment (PDMCI) and with no cognitive impairment (PDNC), we compared regional cerebral glucose metabolism (CMRglc) amongst 13 patients with PDMCI, 27 with PDNC, and 13 healthy controls. The PDNC patients had limited areas of hypometabolism in the frontal and occipital cortices. In the PDMCI patients, there were extensive areas of hypometabolism in the posterior cortical regions, including the temporo-parieto-occipital junction, medial parietal, and inferior temporal cortices. The present results suggest that posterior cortical dysfunction is the primary neuroimaging feature of PD patients at risk for dementia.
CC : 002B17; 002B17G
FD : Maladie de Parkinson; Déficit cognitif léger; Trouble cognitif; Pathologie du système nerveux; Encéphale; Glucose; Métabolisme; Tomoscintigraphie; Tomographie par émission de positons
FG : Système nerveux central; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central
ED : Parkinson disease; mild cognitive impairment; Cognitive disorder; Nervous system diseases; Encephalon; Glucose; Metabolism; Emission tomography; Positron emission tomography
EG : Central nervous system; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease
SD : Parkinson enfermedad; Disturbio cognitivo ligero; Trastorno cognitivo; Sistema nervioso patología; Encéfalo; Glucosa; Metabolismo; Tomocentelleografía; Tomografía emisión positrones
LO : INIST-20953.354000186181820090
ID : 09-0223194

Links to Exploration step

Pascal:09-0223194

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment</title>
<author>
<name sortKey="Hosokai, Yoshiyuki" sort="Hosokai, Yoshiyuki" uniqKey="Hosokai Y" first="Yoshiyuki" last="Hosokai">Yoshiyuki Hosokai</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Radiological Technology and Science, School of Health Science, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Nishio, Yoshiyuki" sort="Nishio, Yoshiyuki" uniqKey="Nishio Y" first="Yoshiyuki" last="Nishio">Yoshiyuki Nishio</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hirayama, Kazumi" sort="Hirayama, Kazumi" uniqKey="Hirayama K" first="Kazumi" last="Hirayama">Kazumi Hirayama</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Takeda, Atsushi" sort="Takeda, Atsushi" uniqKey="Takeda A" first="Atsushi" last="Takeda">Atsushi Takeda</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ishioka, Toshiyuki" sort="Ishioka, Toshiyuki" uniqKey="Ishioka T" first="Toshiyuki" last="Ishioka">Toshiyuki Ishioka</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Sawada, Yoichi" sort="Sawada, Yoichi" uniqKey="Sawada Y" first="Yoichi" last="Sawada">Yoichi Sawada</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Suzuki, Kyoko" sort="Suzuki, Kyoko" uniqKey="Suzuki K" first="Kyoko" last="Suzuki">Kyoko Suzuki</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Clinical Neuroscience, Graduate School of Medicine, Yamagata University</s1>
<s2>Yamagata</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Itoyama, Yasuto" sort="Itoyama, Yasuto" uniqKey="Itoyama Y" first="Yasuto" last="Itoyama">Yasuto Itoyama</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Takahashi, Shoki" sort="Takahashi, Shoki" uniqKey="Takahashi S" first="Shoki" last="Takahashi">Shoki Takahashi</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Diagnostic Radiology, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Fukuda, Hiroshi" sort="Fukuda, Hiroshi" uniqKey="Fukuda H" first="Hiroshi" last="Fukuda">Hiroshi Fukuda</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Radiology and Nuclear Medicine, Institute of Development, Aging, and Cancer, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mori, Etsuro" sort="Mori, Etsuro" uniqKey="Mori E" first="Etsuro" last="Mori">Etsuro Mori</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">09-0223194</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0223194 INIST</idno>
<idno type="RBID">Pascal:09-0223194</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000E98</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment</title>
<author>
<name sortKey="Hosokai, Yoshiyuki" sort="Hosokai, Yoshiyuki" uniqKey="Hosokai Y" first="Yoshiyuki" last="Hosokai">Yoshiyuki Hosokai</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Radiological Technology and Science, School of Health Science, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Nishio, Yoshiyuki" sort="Nishio, Yoshiyuki" uniqKey="Nishio Y" first="Yoshiyuki" last="Nishio">Yoshiyuki Nishio</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hirayama, Kazumi" sort="Hirayama, Kazumi" uniqKey="Hirayama K" first="Kazumi" last="Hirayama">Kazumi Hirayama</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Takeda, Atsushi" sort="Takeda, Atsushi" uniqKey="Takeda A" first="Atsushi" last="Takeda">Atsushi Takeda</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ishioka, Toshiyuki" sort="Ishioka, Toshiyuki" uniqKey="Ishioka T" first="Toshiyuki" last="Ishioka">Toshiyuki Ishioka</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Sawada, Yoichi" sort="Sawada, Yoichi" uniqKey="Sawada Y" first="Yoichi" last="Sawada">Yoichi Sawada</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Suzuki, Kyoko" sort="Suzuki, Kyoko" uniqKey="Suzuki K" first="Kyoko" last="Suzuki">Kyoko Suzuki</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Clinical Neuroscience, Graduate School of Medicine, Yamagata University</s1>
<s2>Yamagata</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Itoyama, Yasuto" sort="Itoyama, Yasuto" uniqKey="Itoyama Y" first="Yasuto" last="Itoyama">Yasuto Itoyama</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Takahashi, Shoki" sort="Takahashi, Shoki" uniqKey="Takahashi S" first="Shoki" last="Takahashi">Shoki Takahashi</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Diagnostic Radiology, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Fukuda, Hiroshi" sort="Fukuda, Hiroshi" uniqKey="Fukuda H" first="Hiroshi" last="Fukuda">Hiroshi Fukuda</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Radiology and Nuclear Medicine, Institute of Development, Aging, and Cancer, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mori, Etsuro" sort="Mori, Etsuro" uniqKey="Mori E" first="Etsuro" last="Mori">Etsuro Mori</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cognitive disorder</term>
<term>Emission tomography</term>
<term>Encephalon</term>
<term>Glucose</term>
<term>Metabolism</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Positron emission tomography</term>
<term>mild cognitive impairment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Maladie de Parkinson</term>
<term>Déficit cognitif léger</term>
<term>Trouble cognitif</term>
<term>Pathologie du système nerveux</term>
<term>Encéphale</term>
<term>Glucose</term>
<term>Métabolisme</term>
<term>Tomoscintigraphie</term>
<term>Tomographie par émission de positons</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is no consensus with regard to the clinical and neuroimaging characteristics of prodromal dementia in Parkinson's disease (PD). To delineate functional neuroimaging features of PD with mild cognitive impairment (PDMCI) and with no cognitive impairment (PDNC), we compared regional cerebral glucose metabolism (CMRglc) amongst 13 patients with PDMCI, 27 with PDNC, and 13 healthy controls. The PDNC patients had limited areas of hypometabolism in the frontal and occipital cortices. In the PDMCI patients, there were extensive areas of hypometabolism in the posterior cortical regions, including the temporo-parieto-occipital junction, medial parietal, and inferior temporal cortices. The present results suggest that posterior cortical dysfunction is the primary neuroimaging feature of PD patients at risk for dementia.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>24</s2>
</fA05>
<fA06>
<s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>HOSOKAI (Yoshiyuki)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>NISHIO (Yoshiyuki)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>HIRAYAMA (Kazumi)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>TAKEDA (Atsushi)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>ISHIOKA (Toshiyuki)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>SAWADA (Yoichi)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>SUZUKI (Kyoko)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>ITOYAMA (Yasuto)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>TAKAHASHI (Shoki)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>FUKUDA (Hiroshi)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>MORI (Etsuro)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Radiological Technology and Science, School of Health Science, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Department of Neurology, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Department of Clinical Neuroscience, Graduate School of Medicine, Yamagata University</s1>
<s2>Yamagata</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Department of Diagnostic Radiology, Graduate School of Medicine, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Department of Radiology and Nuclear Medicine, Institute of Development, Aging, and Cancer, Tohoku University</s1>
<s2>Sendai</s2>
<s3>JPN</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA20>
<s1>854-862</s1>
</fA20>
<fA21>
<s1>2009</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000186181820090</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>32 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>09-0223194</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>There is no consensus with regard to the clinical and neuroimaging characteristics of prodromal dementia in Parkinson's disease (PD). To delineate functional neuroimaging features of PD with mild cognitive impairment (PDMCI) and with no cognitive impairment (PDNC), we compared regional cerebral glucose metabolism (CMRglc) amongst 13 patients with PDMCI, 27 with PDNC, and 13 healthy controls. The PDNC patients had limited areas of hypometabolism in the frontal and occipital cortices. In the PDMCI patients, there were extensive areas of hypometabolism in the posterior cortical regions, including the temporo-parieto-occipital junction, medial parietal, and inferior temporal cortices. The present results suggest that posterior cortical dysfunction is the primary neuroimaging feature of PD patients at risk for dementia.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Déficit cognitif léger</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>mild cognitive impairment</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Disturbio cognitivo ligero</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Trouble cognitif</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Cognitive disorder</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Trastorno cognitivo</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Encéphale</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Encephalon</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Encéfalo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Glucose</s0>
<s2>NK</s2>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Glucose</s0>
<s2>NK</s2>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Glucosa</s0>
<s2>NK</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Métabolisme</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Metabolism</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Metabolismo</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Tomoscintigraphie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Emission tomography</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Tomocentelleografía</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Tomographie par émission de positons</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Positron emission tomography</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Tomografía emisión positrones</s0>
<s5>13</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Système nerveux central</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Central nervous system</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso central</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Syndrome extrapyramidal</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>166</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 09-0223194 INIST</NO>
<ET>Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment</ET>
<AU>HOSOKAI (Yoshiyuki); NISHIO (Yoshiyuki); HIRAYAMA (Kazumi); TAKEDA (Atsushi); ISHIOKA (Toshiyuki); SAWADA (Yoichi); SUZUKI (Kyoko); ITOYAMA (Yasuto); TAKAHASHI (Shoki); FUKUDA (Hiroshi); MORI (Etsuro)</AU>
<AF>Department of Radiological Technology and Science, School of Health Science, Tohoku University/Sendai/Japon (1 aut.); Department of Behavioral Neurology and Cognitive Neuroscience, Graduate School of Medicine, Tohoku University/Sendai/Japon (1 aut., 2 aut., 3 aut., 5 aut., 6 aut., 7 aut., 11 aut.); Department of Neurology, Graduate School of Medicine, Tohoku University/Sendai/Japon (4 aut., 8 aut.); Department of Clinical Neuroscience, Graduate School of Medicine, Yamagata University/Yamagata/Japon (7 aut.); Department of Diagnostic Radiology, Graduate School of Medicine, Tohoku University/Sendai/Japon (9 aut.); Department of Radiology and Nuclear Medicine, Institute of Development, Aging, and Cancer, Tohoku University/Sendai/Japon (10 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 6; Pp. 854-862; Bibl. 32 ref.</SO>
<LA>Anglais</LA>
<EA>There is no consensus with regard to the clinical and neuroimaging characteristics of prodromal dementia in Parkinson's disease (PD). To delineate functional neuroimaging features of PD with mild cognitive impairment (PDMCI) and with no cognitive impairment (PDNC), we compared regional cerebral glucose metabolism (CMRglc) amongst 13 patients with PDMCI, 27 with PDNC, and 13 healthy controls. The PDNC patients had limited areas of hypometabolism in the frontal and occipital cortices. In the PDMCI patients, there were extensive areas of hypometabolism in the posterior cortical regions, including the temporo-parieto-occipital junction, medial parietal, and inferior temporal cortices. The present results suggest that posterior cortical dysfunction is the primary neuroimaging feature of PD patients at risk for dementia.</EA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Déficit cognitif léger; Trouble cognitif; Pathologie du système nerveux; Encéphale; Glucose; Métabolisme; Tomoscintigraphie; Tomographie par émission de positons</FD>
<FG>Système nerveux central; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central</FG>
<ED>Parkinson disease; mild cognitive impairment; Cognitive disorder; Nervous system diseases; Encephalon; Glucose; Metabolism; Emission tomography; Positron emission tomography</ED>
<EG>Central nervous system; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Parkinson enfermedad; Disturbio cognitivo ligero; Trastorno cognitivo; Sistema nervioso patología; Encéfalo; Glucosa; Metabolismo; Tomocentelleografía; Tomografía emisión positrones</SD>
<LO>INIST-20953.354000186181820090</LO>
<ID>09-0223194</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E98 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000E98 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:09-0223194
   |texte=   Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024